PURPOSE:To determine the prevalence of horizontal strabismus in patients less than 15 years of age. METHODS:A retrospective analysis of data of children attending pediatric OPD from January 2016 to December 2020 was done. A proforma was made and following information was entered information : history, clinical presentation, ocular examination including visual acuity, anterior and posterior segment evaluation,extraocular motility, cover tests, Prism bar cover test,worth four dot test,Bagolini's striated glasses test,Lang test,cycloplegic refraction. RESULTS: A total of 1,17,700 attended the pediatric OPD in 5 year period, prevalence of horizontal strabismus was 1.43%. Exotropia was more common than esotropia. Concomitant deviation was more common than incomitant deviation. CONCLUSION: strabismus is frequently encountered in pediatric clinics now. Proper training of pediatric ophthalmologists is required to give excellent care to these children.

Background: Corona virus disease 2019 (COVID-19) is a public health emergency of international concern. The global population lacks immunity to COVID-19 and is generally susceptible. Underlying conditions, especially chronic respiratory diseases, may affect progression, treatment and prognosis of COVID-19. The majority of people who exposed to COVID-19 suffer only mild respiratory symptoms like cough, cold, difficulty in breathing, etc and these symptoms were correlated with Kaba Suram in the Siddha literature. Case Summary: Siddha Clinical Research Unit, New Delhi (CCRS), Ministry of AYUSH, Govt. of India had reported a patient with confirmed COVID-19 by RT-PCR with bronchial asthma as a co-morbid condition. Recovery time from disease onset to negative test for COVID-19 was 19 days. Conclusion: Since the patient residing in Dwaraka, New Delhi has bronchial asthma as a co-morbid condition, both air pollution and the winter season are likely to increase the severity of the disease. But it was observed that the patient’s condition did not deteriorate, so it could be presumed that the management of COVID-19 with the given Siddha internal medicines and external therapies as a standalone treatment ceased the progress of the disease to a severe stage. Key words: Bronchial Asthma, Corona virus, COVID-19, Kaba Suram, Siddha Medicine.